Pharmaceuticals Global Market Report 2022

Mar 2022| TBR077F| TBRC (Publisher)

Report Highlights

Including: 1) By Drug Type: Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Respiratory Diseases Drugs; Vaccines; Therapeutic Nutrients & Minerals; Substance Abuse and Addiction
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Drug Classification: Branded Drugs; Generic Drugs
Covering: Johnson & Johnson; Novartis AG; Bristol-Myers Squibb; AbbVie; Sanofi S.A.; Pfizer Inc.; GlaxosmithKline; F.Hoffmann-La Roche Ltd.; Merck & Co.; AstraZeneca

Pharmaceuticals Global Market Report 2022 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global pharmaceuticals market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the pharmaceuticals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Pharmaceuticals market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceuticals market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The pharmaceuticals market section of the report gives context. It compares the pharmaceuticals market with other segments of the pharmaceuticals market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, pharmaceuticals indicators comparison.

Frequently Asked Questions (FAQs)

Scope

Markets Covered:

  • By Drug Type: Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Respiratory Diseases Drugs; Vaccines; Therapeutic Nutrients & Minerals; Substance Abuse and Addiction
  • By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
  • By Drug Classification: Branded Drugs; Generic Drugs

Companies Mentioned: Johnson & Johnson; Novartis AG; Bristol-Myers Squibb; AbbVie; Sanofi S.A.

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, pharmaceuticals indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Historic Market Growth, Value ($ Billion)
  • Table 2 : Forecast Market Growth, Value ($ Billion)
  • Table 3 : Global Pharmaceuticals Market, 2021, By Region, Value ($ Billion)
  • Table 4 : Global Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 5 : Global Pharmaceuticals Market, Growth And Market Share Comparison, By Region
  • Table 6 : Global Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7 : Global Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8 : Global Pharmaceuticals Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9 : Global Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 10 : Global Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 11 : Pharmaceuticals Market Size, Percentage Of GDP, 2016-2026, Global
  • Table 12 : Per Capita Average Pharmaceuticals Market Expenditure, 2016-2026, Global
  • Table 13 : Asia-Pacific, Pharmaceuticals Market, 2021, By Country, Value ($ Billion)
  • Table 14 : Asia-Pacific, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 15 : Asia-Pacific, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 16 : Per Capita Average Pharmaceuticals Expenditure, 2016-2026, Asia-Pacific Countries
  • Table 17 : Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2021, Asia-Pacific Countries
  • Table 18 : Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2021, Asia-Pacific Countries
  • Table 19 : Asia-Pacific Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 20 : Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 21 : Asia-Pacific Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 22 : China Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 23 : China Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 24 : China Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 25 : Australia Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 26 : Australia Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 27 : Australia Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 28 : Hong Kong Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 29 : India Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 30 : India Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 31 : India Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 32 : Indonesia Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 33 : Indonesia Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 34 : Indonesia Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 35 : Japan Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 36 : Japan Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 37 : Japan Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 38 : Malaysia Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 39 : New Zealand Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 40 : Philippines Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 41 : Singapore Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 42 : South Korea Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 43 : South Korea Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 44 : South Korea Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 45 : Thailand Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 46 : Vietnam Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 47 : Western Europe, Pharmaceuticals Market, 2021, By Country, Value ($ Billion)
  • Table 48 : Western Europe, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 49 : Western Europe, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 50 : Per Capita Average Pharmaceuticals Expenditure, 2016-2026, Western Europe Countries
  • Table 51 : Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2021, Western Europe Countries
  • Table 52 : Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2021, Western Europe Countries
  • Table 53 : Western Europe Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 54 : Western Europe Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 55 : Western Europe Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 56 : Austria Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 57 : Belgium Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 58 : Denmark Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 59 : Finland Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 60 : France Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 61 : France Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 62 : France Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 63 : Germany Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 64 : Germany Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 65 : Germany Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 66 : Ireland Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 67 : Italy Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 68 : Netherlands Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 69 : Norway Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 70 : Portugal Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 71 : Spain Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 72 : Sweden Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 73 : Switzerland Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 74 : UK Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 75 : UK Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 76 : UK Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 77 : Eastern Europe, Pharmaceuticals Market, 2021, By Country, Value ($ Billion)
  • Table 78 : Eastern Europe, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 79 : Eastern Europe, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 80 : Per Capita Average Pharmaceuticals Expenditure, 2016-2026, Eastern Europe Countries
  • Table 81 : Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2021, Eastern Europe Countries
  • Table 82 : Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2021, Eastern Europe Countries
  • Table 83 : Eastern Europe Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 84 : Eastern Europe Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 85 : Eastern Europe Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 86 : Czech Republic Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 87 : Poland Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 88 : Romania Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 89 : Russia Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 90 : Russia Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 91 : Russia Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 92 : North America, Pharmaceuticals Market, 2021, By Country, Value ($ Billion)
  • Table 93 : North America, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 94 : North America, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 95 : Per Capita Average Pharmaceuticals Expenditure, 2016-2026, North America Countries
  • Table 96 : Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2021, North America Countries
  • Table 97 : Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2021, North America Countries
  • Table 98 : North America Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 99 : North America Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 100 : North America Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 101 : Canada Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 102 : Mexico Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 103 : USA Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 104 : USA Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 105 : USA Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 106 : South America, Pharmaceuticals Market, 2021, By Country, Value ($ Billion)
  • Table 107 : South America, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 108 : South America, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 109 : Per Capita Average Pharmaceuticals Expenditure, 2016-2026, South America Countries
  • Table 110 : Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2021, South America Countries
  • Table 111 : Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2021, South America Countries
  • Table 112 : South America Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 113 : South America Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 114 : South America Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 115 : Argentina Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 116 : Brazil Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 117 : Brazil Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 118 : Brazil Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 119 : Chile Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 120 : Colombia Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 121 : Peru Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 122 : Venezuela Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 123 : Middle East, Pharmaceuticals Market, 2021, By Country, Value ($ Billion)
  • Table 124 : Middle East, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 125 : Middle East, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 126 : Per Capita Average Pharmaceuticals Expenditure, 2016-2026, Middle East Countries
  • Table 127 : Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2021, Middle East Countries
  • Table 128 : Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2021, Middle East Countries
  • Table 129 : Middle East Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 130 : Middle East Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 131 : Middle East Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 132 : Saudi Arabia Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 133 : Israel Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 134 : Turkey Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 135 : UAE Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 136 : Africa, Pharmaceuticals Market, 2021, By Country, Value ($ Billion)
  • Table 137 : Africa, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 138 : Africa, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 139 : Per Capita Average Pharmaceuticals Expenditure, 2016-2026, Africa Countries
  • Table 140 : Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2021, Africa Countries
  • Table 141 : Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2021, Africa Countries
  • Table 142 : Africa Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 143 : Africa Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 144 : Africa Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 145 : Egypt Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 146 : Nigeria Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 147 : South Africa Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 148 : Johnson & Johnson Financial Performance
  • Table 149 : Novartis AG Financial Performance
  • Table 150 : Bristol-Myers Squibb Financial Performance
  • Table 151 : AbbVie Financial Performance
  • Table 152 : Sanofi S.A Financial Performance
  • Table 153 : Global Pharmaceuticals Market In 2026- Growth Countries
  • Table 154 : Global Pharmaceuticals Market In 2026- Growth Segments
  • Table 155 : Global Pharmaceuticals Market In 2026- Growth Strategies
  • Figure 1 : Historic Market Growth, Value ($ Billion)
  • Figure 2 : Forecast Market Growth, Value ($ Billion)
  • Figure 3 : Global Pharmaceuticals Market, 2021, By Region, Value ($ Billion)
  • Figure 4 : Global Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 5 : Global Pharmaceuticals Market, Growth And Market Share Comparison, By Region
  • Figure 6 : Global Pharmaceuticals Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7 : Global Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8 : Global Pharmaceuticals Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9 : Global Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 10 : Global Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 11 : Pharmaceuticals Market Size, Percentage Of GDP, 2016-2026, Global
  • Figure 12 : Per Capita Average Pharmaceuticals Market Expenditure, 2016-2026, Global
  • Figure 13 : Asia-Pacific, Pharmaceuticals Market, 2021, By Country, Value ($ Billion)
  • Figure 14 : Asia-Pacific, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 15 : Asia-Pacific, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 16 : Per Capita Average Pharmaceuticals Expenditure, 2016-2026, Asia-Pacific Countries
  • Figure 17 : Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2021, Asia-Pacific Countries
  • Figure 18 : Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2021, Asia-Pacific Countries
  • Figure 19 : Asia-Pacific Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 20 : Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 21 : Asia-Pacific Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 22 : China Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 23 : China Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 24 : China Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 25 : Australia Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 26 : Australia Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 27 : Australia Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 28 : Hong Kong Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 29 : India Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 30 : India Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 31 : India Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 32 : Indonesia Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 33 : Indonesia Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 34 : Indonesia Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 35 : Japan Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 36 : Japan Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 37 : Japan Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 38 : Malaysia Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 39 : New Zealand Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 40 : Philippines Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 41 : Singapore Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 42 : South Korea Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 43 : South Korea Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 44 : South Korea Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 45 : Thailand Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 46 : Vietnam Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 47 : Western Europe, Pharmaceuticals Market, 2021, By Country, Value ($ Billion)
  • Figure 48 : Western Europe, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 49 : Western Europe, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 50 : Per Capita Average Pharmaceuticals Expenditure, 2016-2026, Western Europe Countries
  • Figure 51 : Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2021, Western Europe Countries
  • Figure 52 : Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2021, Western Europe Countries
  • Figure 53 : Western Europe Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 54 : Western Europe Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 55 : Western Europe Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 56 : Austria Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 57 : Belgium Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 58 : Denmark Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 59 : Finland Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 60 : France Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 61 : France Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 62 : France Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 63 : Germany Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 64 : Germany Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 65 : Germany Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 66 : Ireland Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 67 : Italy Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 68 : Netherlands Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 69 : Norway Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 70 : Portugal Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 71 : Spain Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 72 : Sweden Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 73 : Switzerland Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 74 : UK Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 75 : UK Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 76 : UK Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 77 : Eastern Europe, Pharmaceuticals Market, 2021, By Country, Value ($ Billion)
  • Figure 78 : Eastern Europe, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 79 : Eastern Europe, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 80 : Per Capita Average Pharmaceuticals Expenditure, 2016-2026, Eastern Europe Countries
  • Figure 81 : Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2021, Eastern Europe Countries
  • Figure 82 : Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2021, Eastern Europe Countries
  • Figure 83 : Eastern Europe Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 84 : Eastern Europe Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 85 : Eastern Europe Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 86 : Czech Republic Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 87 : Poland Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 88 : Romania Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 89 : Russia Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 90 : Russia Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 91 : Russia Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 92 : North America, Pharmaceuticals Market, 2021, By Country, Value ($ Billion)
  • Figure 93 : North America, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 94 : North America, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 95 : Per Capita Average Pharmaceuticals Expenditure, 2016-2026, North America Countries
  • Figure 96 : Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2021, North America Countries
  • Figure 97 : Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2021, North America Countries
  • Figure 98 : North America Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 99 : North America Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 100 : North America Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 101 : Canada Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 102 : Mexico Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 103 : USA Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 104 : USA Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 105 : USA Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 106 : South America, Pharmaceuticals Market, 2021, By Country, Value ($ Billion)
  • Figure 107 : South America, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 108 : South America, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 109 : Per Capita Average Pharmaceuticals Expenditure, 2016-2026, South America Countries
  • Figure 110 : Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2021, South America Countries
  • Figure 111 : Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2021, South America Countries
  • Figure 112 : South America Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 113 : South America Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 114 : South America Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 115 : Argentina Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 116 : Brazil Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 117 : Brazil Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 118 : Brazil Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 119 : Chile Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 120 : Colombia Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 121 : Peru Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 122 : Venezuela Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 123 : Middle East, Pharmaceuticals Market, 2021, By Country, Value ($ Billion)
  • Figure 124 : Middle East, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 125 : Middle East, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 126 : Per Capita Average Pharmaceuticals Expenditure, 2016-2026, Middle East Countries
  • Figure 127 : Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2021, Middle East Countries
  • Figure 128 : Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2021, Middle East Countries
  • Figure 129 : Middle East Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 130 : Middle East Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 131 : Middle East Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 132 : Saudi Arabia Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 133 : Israel Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 134 : Turkey Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 135 : UAE Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 136 : Africa, Pharmaceuticals Market, 2021, By Country, Value ($ Billion)
  • Figure 137 : Africa, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 138 : Africa, Pharmaceuticals Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 139 : Per Capita Average Pharmaceuticals Expenditure, 2016-2026, Africa Countries
  • Figure 140 : Number of Enterprises, Pharmaceuticals Market, Pharmaceuticals Market/Number of Enterprises, 2021, Africa Countries
  • Figure 141 : Number of Employees, Pharmaceuticals Market, Pharmaceuticals Market/Number of Employees, 2021, Africa Countries
  • Figure 142 : Africa Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 143 : Africa Pharmaceutical Drugs Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 144 : Africa Biologics Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 145 : Egypt Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 146 : Nigeria Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 147 : South Africa Pharmaceuticals Market, Segmentation By Drug Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 148 : Johnson & Johnson Financial Performance
  • Figure 149 : Novartis AG Financial Performance
  • Figure 150 : Bristol-Myers Squibb Financial Performance
  • Figure 151 : AbbVie Financial Performance
  • Figure 152 : Sanofi S.A Financial Performance
  • Figure 153 : Global Pharmaceuticals Market In 2026- Growth Countries
  • Figure 154 : Global Pharmaceuticals Market In 2026- Growth Segments
  • Figure 155 : Global Pharmaceuticals Market In 2026- Growth Strategies

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Pharmaceuticals Global Market Report 2021: COVID 19 Impact and Recovery to 2030

  • Date - Feb 2021
  • Code - TBR077E

Including: 1) By Type: Pharmaceutical Drugs; Biologics
2) By Distribution Channel: Supermarkets/Hypermarkets; Convenience Stores; E-Commerce; Others
3) By Nature: Organic; Conventional

Covering: Pfizer; F. Hoffmann-La Roche Ltd; Sanofi; Johnson & Johnson; Merck & Co.

Pharmaceuticals Global Market Report 2021: COVID 19 Impact and Recovery to 2030 from The Business Research Company provides the strategists, marketers and senior management ...

Pharmaceuticals Global Market Opportunities And Strategies To 2030: COVID 19 Impact and Recovery

  • Date - Aug 2020
  • Code - TBR077D

Including: By Type: Pharmaceutical Drugs; Biologics
By Pharmaceutical Drugs Type: Metabolic Disorders Drugs; Central Nervous System Drugs; Anti-Infective Drugs; Cardiovascular Drugs; Musculoskeletal Disorders Drugs; Oncology Drugs; Hematology Drugs; Respiratory Diseases Drugs; Genito-Urinary Drugs; Gastrointestinal Drugs; Dermatology Drugs; Ophthalmology Drugs
By Biologics Drugs Type: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccine

Covering: Pfizer Inc.; F. Hoffmann-La Roche AG; Novartis AG; Johnson & ...

Pharmaceuticals Global Market Strategic Briefing 2020: Covid 19 Impact and Recovery

  • Date - Jun 2020
  • Code - TBR077C

Including: Pharmaceutical Drugs; Biologics

The global pharmaceuticals market is expected to grow from $1205.5 billion in 2019 to $1237.5 billion in 2020 at a CAGR of 2.66%, despite the economic slowdown across countries owing to the pandemic outbreak. The market is then expected to grow at a CAGR of 7.72% from 2020 to reach $1546.7 billion in 2023.

Pharmaceuticals Global ...

Pharmaceuticals Global Market Report 2020-30: Covid 19 Impact and Recovery

  • Date - May 2020
  • Code - TBR077B

Including: 1) By Type: Pharmaceutical Drugs; Biologics
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Covering: Pfizer; F. Hoffmann-La Roche Ltd; Sanofi; Johnson & Johnson; Merck & Co.

Pharmaceuticals Global Market Report ...

Pharmaceuticals Global Market Report 2019

  • Date - Jan 2019
  • Code - TBR077A

Including: Pharmaceutical Drugs, Biologics , Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorders Drugs, Musculoskeletal Disorders Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs, Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines

Covering: Pfizer, F. Hoffmann-La Roche Ltd, Sanofi, Johnson & Johnson, Merck & Co.

The Business Research Company
Price: $6000

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS